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Abstract
Background: With a national program initiated recently to reduce transmission of Schistosoma japonicum in the People’s
Republic of China (P.R. China), there is an urgent need for accessible, quality-assured diagnostics for case detection,
surveillance, and program monitoring of chemotherapy efficacy and other control interventions in areas of low endemicity.
We compared the performance of nine immunodiagnostic tests developed in P.R. China for detection of antibodies against
S. japonicum and established their priority for further assessment in field settings.
Methodology/Principal Findings: Using the Kato-Katz technique as the reference standard, 240 well-characterized archived
serum specimens (100 positive and 140 negative) were evaluated in nine immunological tests developed in P.R. China. The
enzyme-linked immunoelectrotransfer blot assay (EITB), which uses an adult worm extract of S. japonicum, supplied by the
Center of Disease Control and Prevention, USA, was also evaluated. The sensitivity and specificity of each test were
determined and the reproducibility of each test was assessed by evaluating operator-to-operator and run-to-run variation.
In addition the simplicity of use for the end-user was evaluated. All tests showed good sensitivities ranging from 92.0% (95%
confidence interval (CI): 86.7–97.3%) to 98.0% (95% CI: 95.3–100.0%). The test specificities varied from 70.0% (95% CI: 62.4–
77.6%) to 97.1% (95% CI: 94.4–99.9%). All tests showed excellent reproducibility with a discordant rate in the range of 0–
10.0% for operator-to-operator variation and run-to-run variation. All tests, except one magnetic particle-based enzyme-
linked immunosorbent assay, were found to be easy to use, especially the dot immunogold filtration assays.
Conclusions/Significance: Most evaluated tests had acceptable performance characteristics and could make an impact on
the schistosomiasis control programs in P.R. China. Three tests with the highest sensitivity, specificity and greatest ease of
use, were selected for further evaluation in field settings.
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Introduction
Schistosomiasis, caused by infection with Schistosoma spp.,
remains a public health problem in tropical and subtropical areas
of the world. It is currently estimated that 207 million people
harbor the parasites and about 779 million people are at risk of
being infected with schistosomes [1]. Among three main disease-
causing species, namely Schistosoma mansoni, S. haematobium, and S.
japonicum, the later is the only species endemic in the People’s
Republic of China (P.R. China). Through more than a half
century of effort, the prevalence and intensity of S. japonicum
infection have decreased significantly resulting in a decrease in the
number of infected people, from 11.6 million in the 1950s to about
0.73 million in 2004 [2–4]. According to the latest national
epidemiological sampling survey, the average prevalence rate was
2.5% in all surveyed endemic areas and 5.1% in the areas where
control of schistosomiasis transmission had not been achieved [4].
With the ultimate goal of elimination, a national program was
initiated in 2004, with specific objectives to decrease the
prevalence of schistosome infection in all endemic counties below
5% in 2008 and 1% in 2015 [5–7]. To reach these goals, accurate,
simple, and affordable diagnostic tests are needed urgently for case
detection, surveillance, and program evaluation, including evalu-
ation of control interventions and verification of elimination of
schistosomiasis in areas with very low endemicity.
Demonstration of eggs or miracidia in the feces is considered to
be the ‘gold’ standard for the identification of S. japonicum infections
[8]. The Kato-Katz technique is frequently used in the field because
it is quantitative, inexpensive, and easy to use [9], but it can be
plagued by decreased sensitivity in areas of low endemicity and
particularly in individuals with low worm burdens [10–12]. The
sensitivity of the Kato-Katz technique can be improved by repeated
stool collection and examination but this is more labor intensive and
costly [10–13]. Nucleic acid amplification techniques based on
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polymerase chain reaction (PCR) have been reported for S. japonicum
detection [14–17]. However, the methods are not standardized and
their sensitivity needs to be verified further. Moreover, the
equipment, personnel, and financial investments required are too
costly for primary health-care settings in P.R. China.
With the advantages of higher sensitivity and ease of use over stool
examination, immunological techniques and methods for antibody
detection have attracted scientists’ attention. Two national collabo-
rative studies to evaluate the antigens used for detection of antibodies
against S. japonicum were organized in the 1980’s and the results
showed crude soluble antigens extracted from parasite eggs
performed with the highest sensitivity and specificity [18,19]. For
unknown reasons, no single test evaluated in these studies was further
developed or widely adopted in P.R. China. Based on the findings of
these previous studies using crude egg antigens, a variety of immuno-
diagnostic methods such as the circumoval precipitin test (COPT),
indirect hemagglutination assay (IHA), enzyme-linked immunosor-
bent assay (ELISA), dipstick dye immunoassay (DDIA) and dot
immunogold filtration assay (DIGFA) have been developed and
integrated into national control programs in P.R. China [4,8,20.21].
Although a number of immunodiagnostic kits have been widely used
in the field in P.R. China, none had been standardized and licensed
by 2008. Furthermore, due to the lack of strict regulatory approval
standards, several poorer performing diagnostics are also used.
Because so many different tests with differing performance
characteristics are being used, it is difficult to interpret the reported
data on prevalence of schistosome infection accurately.
In order to pre-qualify available diagnostic tests for S. japonicum
infection and identify their priorities for future field trials [22], a
laboratory-based evaluation for test performance and operational
characteristics using panels of well-characterized archived serum
specimens from geographically diverse settings of P.R. China was
carried out. The study was also extended to include an evaluation
of the enzyme-linked immunoelectrotransfer blot assay (EITB)
provided by the Center for Disease Control and Prevention
(CDC), USA, to determine its utility as an independent reference
method for confirmation of cases in low transmission areas.
Materials and Methods
Selection of tests for evaluation
Considering the urgent need for quality-assured and approved
reagents for diagnosis of schistosome infection in P.R. China,
letters of invitation and the study protocol were sent to companies
and institutes, and only products that met the following criteria
were included for evaluation: (1) tests which have been used in
field or clinical settings with reported performance characteristics;
(2) tests which could be performed with only minimal training; and
(3) products which were in the licensing process. Tests were
donated by companies or institutes who were interested in
participation in the evaluation, and all test packages were stored
according to manufacturers’ instructions prior to, and during the
evaluation. Well-characterized archived human serum specimens
from the serum bank of the China National Reference Center for
Schistosomiasis Diagnosis (based at the National Institute of
Parasitic Diseases, Chinese Center for Disease Control and
Prevention, abbreviated as IPD, China CDC), which were
collected in October 2007, were used to evaluate the validity
and reproducibility of tests. The examinations were conducted by
well trained technicians in a double blind way and operational
characteristics of the tests were assessed in one week in May, 2008.
Collection and handling of specimens
Serum specimens from patients infected with S. japonicum were
collected in endemic areas in Jiangxi, Anhui and Hubei provinces,
P.R. China. S. japonicum infection was diagnosed on the basis of the
‘gold’ standard method, demonstration of schistosome eggs in feces
with the Kato-Katz technique [9]. Nine slides (41.7 mg feces in
each slide) were prepared from three separate stool specimens
(three slides for each sample), resulting in evaluation of a total
sample weight of 375.3 mg per person. Egg counts reflecting the
infection intensity were expressed in eggs per gram of feces (EPG).
Sera were collected from healthy people living in Shandong
province who had never traveled to schistosomiasis endemic areas
when they underwent routine health check-ups. Serum specimens
were also collected from patients with heterologous infections, i.e.,
hepatitis B, food-borne parasitic diseases (e.g. paragonimiasis,
clonorchiasis, and trichinellosis) and soil-transmitted helminthiases
(ascariasis, hookworm disease and trichuriasis) in areas free of
schistosome infections.
Heterologous infections were diagnosed by stool examinations
and/or specific serological tests. Blood samples of 5–10 ml from
each donor were collected by venipuncture. Whole blood was kept
at 4uC overnight for complete clot retraction. Whole blood was
centrifuged and the serum was removed and divided among
individual serum storage tubes. Aliquots of serum were frozen at
270uC and linked by a unique numerical code to detailed clinical
and parasitological information.
Preparation of serum panels for evaluation
Assuming a sensitivity and specificity of 90% and 90%,
respectively, against the ‘gold’ standard test, and allowing a 6%
margin of error, a serum panel sample size of 240 was used for the
evaluation. One hundred sera were collected from S. japonicum
egg-positive persons, which were characterized as 73.0% (73/100)
male, with a mean age of 47613 years. The median infection
intensity in patients was 9 EPG and 89.0% had infection intensities
below 40 EPG. Fifty serum specimens from healthy persons and
90 specimens from patients with other heterologous diseases (20
cases with hepatitis B, 20 cases with paragonimiasis, and 10 cases
each with trichinellosis, clonorchiasis, ascariasis, hookworm
disease, and trichuriasis) were also included. Ten aliquots (0.1 ml
per aliquot) were prepared per serum specimen and each aliquot
was coded with a unique study ID.
For the assessment of reproducibility, panels were prepared with
19 specimens from patients with schistosomiasis and 11 specimens
Author Summary
With the advantages of higher sensitivity and simpler ease
of use over stool examination, antibody-detection meth-
ods have been integrated into programs for schistosomi-
asis control in the People’s Republic of China after the
notable decrease of prevalence and intensity of Schistoso-
ma japonicum infection. We compared the performance of
nine immunoassays for diagnosis of S. japonicum using
well-characterized archived serum specimens and priori-
tized tests for future evaluation. Most tests had acceptable
performance characteristics and could have an impact on
the control of schistosomiasis. Three tests, including one
indirect hemagglutination assay, one enzyme-linked im-
munosorbent assay and one dot immunogold filtration
assay were selected for further assessment in field settings.
Our final goal is to have appropriate tools for different
stages of schistosomiasis control, such as screening targets
for chemotherapy, evaluating the efficacy of schistosomi-
asis control programs, and monitoring the endemic status
of schistosomiasis.
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from healthy persons. Each specimen was divided by 40 aliquots
(0.1 ml per aliquot) and labeled randomly with unique number.
Tests for evaluation
A total of nine immunodiagnostic kits developed in P.R. China
met the inclusion criteria for evaluation. The antigen for all tests
was the crude soluble egg extract of S. japonicum and the type of
specimen tested in all kits was serum. According to assay type,
these kits were classified into three categories: IHA (four tests
coded as IHA_AJ, IHA_JX, IHA_XY, and IHA_HB), DIGFA
(three tests coded as DIGFA_SH, DIGFA_XC and DIGFA_ZJ),
and ELISA (two tests coded as ELISA_SZ and MELISA_BE).
Major features of these tests are given in Table 1.
The four IHA tests were based on an indicator system consisting
of sheep red blood cell or human red blood cell with ‘‘O’’ blood
type coated with soluble antigen extracted from S. japonicum eggs.
The IHA tests were performed as described in previous studies
[23–28]. The titer in the test sera was recorded as one dilution
before that which yielded a clear, sharp dark spot similar to that in
the negative control wells. Titers were expressed as reciprocal
values. Titers of $10 indicated a positive result.
The three DIGFA tests were based on the immunofiltration
technique, using anti-human antibody labeled with colloidal gold
as the indicator system. The volumes of specimen and reaction
liquid were added according to the instructions provided by their
manufacturers. For the DIGFA_SH and DIGFA_XC, the
appearance of two red dots in the well indicated a positive
reaction, and the appearance of a single red dot indicated a
negative reaction [29,30]. For the DIGFA_ZJ, the color of one dot
in the well equivalent to or deeper than that of positive control
serum was considered a positive result, while only pale or pink
background in the well was defined as a negative result [31].
The ELISA_SZ and MELISA_BE were based on the indirect
ELISA method but differed significantly in their operational
procedures. In the ELISA_SZ, all serum specimens were diluted
1:100 and transferred into the kit supplied microtiter wells. The
incubation procedure, washing steps and detection steps were
carried out according to the manufacturer’s instructions. Optical
density (OD) values were read at 450 nm zeroed by the reagent
blank wells. For each run, positive and negative control sera were
measured simultaneously. A positive result was defined as an OD
value greater than 2.1 times the OD value of the negative control
serum provided by the kit, as specified by the manufacturer’s
instructions [32]. The MELISA_BE test combined indirect ELISA
and magnetic particle isolation techniques to identify antibodies
against S. japonicum [33]. Briefly, serum specimens diluted 1:200
and fluorescein isothiocyanate (FITC) labeled S. japonicum SEA
were added to each tube successively. All the washing steps and
detection steps were performed as described previously [33]. OD
values were read at 550 nm zeroed by the reagent blank wells and
the positives were defined as OD values greater than 0.635.
Finally, an EITB supplied by CDC, USA, was also evaluated.
The EITB was performed as described in previous reports [34]. A
positive result was defined as the appearance of any of three
distinct glycoproteins with molecular masses of 18KD, 23KD and
29KD.
Performance of evaluation
To assess assay performance, each assay was tested with a panel
of 240 serum specimens. The testers were blinded to reference
standard results and performed the tests independently to avoid
comparison of results between kits. Test reproducibility was
investigated using a panel of 30 serum specimens. Operator-to-
operator reproducibility was compared with two technicians who
ran tests with the same 30 sera. Run-to-run variability was
investigated using 30 sera that were tested on two different days for
each test by the same testers.
Each test was assessed for its operational characteristics by the
testing technicians. Tests were scored for clarity of the kit
instructions (very clear = 3, clear = 2, not clear = 1), technical
complexity (,5 steps and short intervals between steps = 3; 5–10
steps and short intervals between steps = 2; $10 steps or long
Table 1. Major features of the evaluated tests for the diagnosis of S. japonicum infection.
Assay
code Assay type Antigen* Solid phase
No. samples
per run
(min. - max.)
Time required
per run
Volumes
of sample
Extra
supplies** References
IHA_AJ Indirect hemagglutination SEA Red cell from sheep 1–30 ,1 h 25 ml Yes 23,24
IHA_HB Indirect hemagglutination SEA Red cell from sheep 1–30 ,1 h 25 ml Yes 25
IHA_XY Indirect hemagglutination SEA Red cell from sheep 1–30 ,1 h 25 ml Yes 26
IHA_JX Indirect hemagglutination SEA Red cell from humans
with ‘‘O’’ type blood
1–30 ,1 h 25 ml Yes 27,28
DIGFA_SH Dot immunogold filtration
assay
SEA Nitrocellulose
membrane
1 ,5 min 50 ml No 29
DIGFA_XC Dot immunogold filtration
assay
SEA Nitrocellulose
membrane
1 ,5 min 40 ml No 30
DIGFA_ZJ Dot immunogold filtration
assay
SEA Nitrocellulose
membrane
1 ,5 min 25 ml No 31
ELISA_SZ Indirect ELISA SEA Microtitre plate 1–96 ,2 h 5 ml Yes 4,32
MELISA_BE Magnetic particle-based
ELISA
SEA Magnetic particle 1–30 ,2 h 5 ml Yes 33
EITB Enzyme-linked
immunoelectrotransfer
blot assay
AWA Nitrocellulose
membrane
1–10 Overnight 3 ml Yes 34
*SEA = soluble egg antigen, AWA = adult microsomal antigen.
**Additional equipment of all tests required was consisted of handheld micropipettes and micropipette tips.
doi:10.1371/journal.pntd.0000949.t001
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intervals between steps = 1) and ease of interpretation (by eye and
easy = 3, by eye but not easy= 2, by machine= 1). The maximum
possible score for each index was 3. In addition, a score of 1 was
given to the tests that did not require any additional equipment,
giving a maximum score of 10. The higher the score, the more
suitable the test was considered for use in the field.
Statistics
All data were processed and analyzed with SPSS statistical
software package 13.0 for Windows (SPSS Inc., Chicago, IL,
USA). Sensitivities and specificities were calculated relative to the
‘gold’ standard Kato-Katz results that correlated to each serum
specimen. The 95% confidence intervals (CIs) were determined for
the sensitivity and specificity of each test. Youden’s index,
expressed as sensitivity + specificity - 1, was used to assess the
ability of the test to discriminate true positives and true negatives.
Operator-to-operator and run-to-run variability were calculated as
the number of tests for which different results were obtained by
two independent operators, two different days, divided by the
number of specimens tested. Categorical variables between groups
were compared by x2 test or Fisher’s exact test as appropriate.
Significance was assigned at P,0.05 for all parameters and was
two-sided unless otherwise indicated.
Ethics statement
The study was approved by the Ethics Committee of IPD,
China CDC. The study procedures, potential risks, and benefits
were explained to the village leaders. After their consent to
perform the study, field workers visited the homes of the selected
families where detailed information was provided to all potential
participants, and questions were answered. All adult participants
and parents/guardians of child participants in a given household
provided informed consent. Written confirmation that full
information had been provided and individual participation was
voluntary (informed consent) was obtained from the head of each
participating household or a literary substitute (adult or relative),
and this procedure was approved by the aforementioned ethical
committee.
Collection of serum specimens was conducted with approval
from the Ethics Committee and Academic Board of IPD, China
CDC. All personal identifiers and patient information were
delinked from the serum specimens.
Results
The sensitivity of each immunological test using 100 serum
specimens collected from S. japonicum-infected individuals is
detailed in Table 2. The IHA_HB, MELISA_BE and EITB tests
performed with the highest sensitivities, 98.0% (98/100; 95% CI:
95.3–100.0%), while the IHA_JX and DIGFA_SH tests showed
the lowest sensitivities (92.0%; 92/100; 95% CI: 86.7–97.3%). The
nine evaluated tests did not differ from EITB in sensitivity
(P.0.05). The 47 false negative specimens were mostly from
patients with 20 or less EPG.
The cross-reactivity with heterologous serum specimens and
specificity of each evaluated test is listed in Table 3. Cross-
reactivity mainly resulted with sera from patients with paragon-
imiasis (false positive rates: 40.0–60.0%) for all tests except the
EITB. Otherwise, false positive rates of each test were very low (0–
20%) for patients infected with soil-transmitted helminths,
including ascariasis, hookworm disease, and trichuriasis. The
highest specificity was observed with the EITB, 97.1% (136/140;
95% CI: 94.4–99.9%). The DIGFA_SH showed the highest
specificity (95.1%; 116/122; 95% CI: 91.2–98.9%) among the
other nine tests developed in P.R. China, while IHA_XY
performed with the lowest specificity (70.0%; 98/140; 95% CI:
62.4–77.6%).
The specificity of each two tests was compared (Table 4). The
specificity of IHA_XY was significantly lower than those of other
evaluated tests. Compared to the EITB, which had the highest
specificity, four tests (IHA_XY, IHA_AJ, IHA_HB, and DIG-
FA_ZJ) performed with significantly lower specificities (P ,0.05).
The other five tests, which did not differ from the EITB in
specificity, also showed no difference between any two tests
(P.0.05).
Overall assay performance was evaluated using Youden’s
indices (Fig. 1). Except for the IHA_XY, all tests demonstrated
good performance as indicated by Youden’s indices higher than
0.80, especially the MELISA_BE and the EITB (0.92 and 0.95,
respectively).
For all tests, reproducibility was measured by determining
operator-to-operator and run-to-run variation. The results are
summarized in Fig. 2. Overall, variability was low. The maximum
variability observed was 10.0% (6/60) for DIGFA_ZJ test for
operator-to-operator and run-to-run variation, respectively, while
no variance was detected in the IHA_AJ, IHA_HB, and
Table 2. Detection of antibodies in S. japonicum egg-positive patients (n = 100).
Assay code
No. of true
positives
No. of false
negatives No. of EPG* for misdiagnosed Sensitivity (%) [95% CI]
P value
against EITB
IHA_AJ 93 7 3, 3, 5, 5, 16, 21, 139 93.0 [88.0–98.0] 0.17
IHA_HB 98 2 5, 21 98.0 [95.3–100.0] 1
IHA_XY 96 4 3, 5, 11, 139 96.0 [92.2–99.8] 0.68
IHA_JX 92 8 3, 3, 5, 11, 19, 21, 27, 139 92.0 [86.7–97.3] 0.1
DIGFA_SH 92 8 3, 5, 5, 5, 8, 11, 11, 37 92.0 [86.7–97.3] 0.1
DIGFA_XC 97 3 11, 24, 37 97.0 [93.7–100.0] 1
DIGFA_ZJ 94 6 3, 5, 5, 5, 11, 37 94.0 [89.3–98.7] 0.28
MELISA_BE 98 2 5, 21 98.0 [95.3–100.0] 1
ELISA_SZ 95 5 3, 3, 5, 8, 37 95.0 [90.7–99.3] 0.45
EITB 98 2 11, 35 98.0 [95.3–100.0] -
*EPG: egg per gram feces.
doi:10.1371/journal.pntd.0000949.t002
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ELISA_SZ assays. The scores for operational characteristics are
summarized in Table 5. Three DIGFA assays obtained the best
scores on the questionnaire (10/10) but all presented technical
problems with membrane permeability, as evidenced by several
serum specimens that could not penetrate. The MELISA_BE
received the lowest score (5/10). All tests scored 3 for clarity of kit
instructions. Given the similar test principles, four IHA assays and
three DIGFA assays were scored equally for technical complexity
(2/3, 3/3, accordingly), while MELISA_BE and EITB scored the
lowest (1/3). The three DIGFAs scored the highest for ease of
interpretation (3/3) and no extra equipment except handheld
micropipettes and micropipette tips was needed. The MELI-
SA_BE and ELISA_SZ scored the lowest on ease of interpretation
because results were generated using an enzyme-linked analyzer.
Discussion
Parasitological techniques, the definitive methods for determin-
ing S. japonicum infection, are relatively insensitive in populations
with light infections, as is the case in P.R. China after years of
integrated schistosomiasis control [20,24,35]. Other diagnostic
alternatives include immunologic methods for detection of
Table 3. False positive results of the evaluated immunoassays.
Assay code No. false positives
Specificity
(%) [95%
CI**]
Healthy
persons
n=50
Hepatitis B
n=20*
Clonorchiasis
n =20
Paragonimiasis
n =10*
Trichinellosis
n=10
Ascariasis
n=10
Hookworm
disease
n=10
Trichuriasis
n=10
Total
n =40*
IHA_AJ 3 1 2 5 2 0 0 1 14 90.0
[85.0–95.0]
IHA_HB 4 1 2 6 3 0 0 2 18 87.1
[81.6–92.7]
IHA_XY 15 4 10 6 6 0 1 0 42 70.0
[62.4–77.6]
IHA_JX 1 0 1 5 2 0 0 1 10 92.9
[88.6–97.1]
DIGFA_SH 1 0 (7) 1 2 (5) 2 0 0 0 6 (122) 95.1
[91.2–98.9]
DIGFA_XC 0 0 (11) 1 4 (9) 3 1 0 0 9 (130) 93.1
[88.7–97.4]
DIGFA_ZJ 1 1 (13) 0 6 (9) 3 0 1 0 12 (132) 90.9
[86.0–95.8]
MELISA_BE 1 0 1 5 1 0 0 0 8 94.3
[90.5–98.1]
ELISA_SZ 2 1 0 5 1 0 0 0 9 93.6
[89.5–97.6]
EITB 1 0 1 0 2 0 0 0 4 97.1
[94.4–99.9]
*() indicates number of tests that gave valid results;
**CI: confidence interval.
doi:10.1371/journal.pntd.0000949.t003
Table 4. Comparative differences in testing specificity (P values).
Assay code IHA_AJ IHA_HB IHA_XY IHA_JX DIGFA_SH DIGFA_XC DIGFA_ZJ MELISA_BE ELISA_SZ EITB
IHA_AJ
IHA_HB 0.452
IHA_XY ,0.001** ,0.001**
IHA_JX 0.393 0.111 ,0.001**
DIGFA_SH 0.122 0.026* ,0.001** 0.453
DIGFA_XC 0.365 0.104 ,0.001** 0.944 0.501
DIGFA_ZJ 0.272 0.727 ,0.001** 0.053 0.011* 0.051
MELISA_BE 0.276 0.068* ,0.001** 0.812 0.600 0.871 0.031*
ELISA_SZ 0.183 0.039* ,0.001** 0.626 0.775 0.683 0.017* 0.802
EITB 0.026* 0.003* ,0.001** 0.168 0.522 0.157 0.001* 0.255 0.377
*indicate significant difference;
**indicate highly significant difference.
doi:10.1371/journal.pntd.0000949.t004
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parasitic specific antibodies or circulating antigens. Although a
number of monoclonal antibodies developed for detection of
circulating antigens have been developed in P.R. China, these
assays showed unsatisfactory sensitivity, especially in patients with
light infections [36–38]. Antibody-detection has been shown to be
more sensitive than stool examination and is needed in areas
characterized by low level of transmission, low prevalence and
particularly low intensity [39–41]. To identify quality-assured
diagnostic assays for use in schistosomiasis control areas with low
endemicity, we compared diagnostic tests developed in P.R. China
in a controlled laboratory setting using well-characterized archived
serum specimens (Figure S1), and prioritized the methods for
further assessment in field settings.
Once transmission of the disease drops to very low levels, the
positive predictive value for any test is decreased. Therefore a
confirmatory method may be needed to verify results obtained in
the field, especially in areas of low prevalence. The ideal
confirmatory method should be independent of the first test
method to increase the statistical reliability of the results. The
EITB methods using S. mansoni and S. haematobium adult worm
microsomal fractions have been demonstrated to be a highly
sensitive and specific for detection of schistosomiasis caused by
these species [34,42]. The EITB using S. japonicum adult worm
microsomal fractions was evaluated here to determine if this test
would be a suitable reference method to confirm S. japonicum
infections in especially low transmission settings. The EITB was
also chosen for evaluation here because the assay format is
independent of the other methods evaluated in this study, all of
which detect antibodies to egg antigens. Instead the EITB detects
antibodies to adult worm antigens presented in the microsomal
fraction and thereby provides an independent means of confirming
positives identified using the field tests. In this study, the EITB
performed with a high sensitivity for detection of patients with
light S. japonicum infections and also had a low cross-reaction rate
with normal or heterologous sera. Considering these data and
other studies, the EITB has been demonstrated to be effective and
specific for detection of schistosome infections. For these reasons,
we have identified the EITB as a possible method for definitive
serodiagnosis of S. japonicum infections.
The nine other diagnostic tests evaluated demonstrated a good
ability to identify schistosomiasis patients with light infections, with
sensitivities in the range of 92.0% (95% CI: 86.7–97.3%) to 98.0%
(95% CI: 95.3–100.0%). This observation is consistent with a
previous study performed by our laboratory with archived serum
specimens, in which most immunoassays had sensitivities above
90% [43]. We also found that the serum specimens that generated
the most false negative results were collected from patients with
very low infection intensities (generally less than 20 EPG). Thus,
more sensitive assays need to be developed to avoid misidentifying
those individuals with low level infections, but who pose a
tremendous risk for continuing transmission. There are quite a few
reports of PCR-based methods for detecting S. japonicum infection
[14–17]. Although the application of molecular techniques in field
studies needs further evaluation, these techniques could be
improved and standardized as laboratory reference or confirma-
tory assays because of their excellent sensitivity and specificity.
The specificities of the nine assessed tests in P.R. China varied
greatly and ranged from 70.0% (95% CI: 62.4–77.6%) to 95.1%
(95% CI: 91.2–98.9%). Four tests, including the IHA_AJ,
IHA_HB, IHA_XY, and DIGFA_ZJ, with specificities lower than
91%, differed significantly in specificity from that of the EITB
(specificity: 97.1%, 95% CI: 94.4–99.9%). The remaining five
assays, IHA_JX, DIGFA_SH, DIGFA_XC, MELISA_BE and
ELISA_SZ, did not differ between any two tests in specificity. The
specificities of the evaluated tests were mainly influenced by the
cross-reactivity with specimens from paragonimiasis or trichinel-
losis patients. These observations suggested that when a positive
result is obtained for a patient from an area co-endemic with
schistosomiasis and paragonimiasis or trichinellosis, the history of
infection with, or exposure to, the other two diseases should be
considered also.
Figure 1. Validity of evaluated tests for the diagnosis of S.
japonicum infection (Youden’s index).
doi:10.1371/journal.pntd.0000949.g001
Figure 2. Test reproducibility results (discordance %). A: Operator-to-operator variability (n = 60). B: Run-to-run variability (n = 60).
doi:10.1371/journal.pntd.0000949.g002
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In addition to high sensitivity and specificity, an ideal diagnostic
test to be considered for use in developing countries should be
user-friendly, rapid and robust, require simple or no equipment,
be deliverable to end-users, and be manufactured according to
quality standards [44,45]. First, reproducibility, which is a
measure of the closeness of agreement between test results when
the conditions for testing or measurement change [46], is an
intrinsic factor that may affect performance especially when used
in the field for a large-scale evaluation. Our study measured the
reproducibility of assays by determining operator-to-operator and
run-to-run variation. The discordant rate in the range of 0-10.0%
indicates that all tests performed with good reproducibility.
Second, the operational characteristics of each test were assessed
based on a questionnaire administered to technicians performing
the assays. Results from the questionnaire indicated that three
DIGFA tests had the greatest advantage for field use, because of
their short time to test completion, no extra equipment
requirements and ease of interpreting results. We did note that
membrane permeability needs to be improved in the DIGFA
assays. Further modification for the DIGFA_SH and DIGFA_XC
methods is necessary because the specimen volumes needed
requires collection of whole blood via venipuncture. This is a
limitation because well trained personnel are required and the
practice is not always widely accepted in all populations. A later
assessment of modified DIGFA tests, which only required a 25 ml
serum specimen showed improved membrane permeability;
however, only the DIGFA_SH still had high sensitivity and
specificity, while the sensitivity of the other two DIGFA tests had
decreased below 90% (data not shown). The IHA tests are the
most widely used assays in P.R. China and no technical problems
with these were identified except the need for an incubator. The
ELISA_SZ, which had a high sensitivity and specificity and could
detect specimens in panels and give quantitative results based on
OD values, is more suitable for a large-scale community survey.
However, the needs for a 37uC incubator and a microplate reader
for results interpretation limit its use to settings with some
moderate amount of laboratory resources. The MELISA_SE,
which performed with highest sensitivity and specificity, similar to
the EITB, is more appropriate for use as a reference laboratory
method or a clinical diagnostic assay because of its complicated
procedures and instrument requirements. If it is to be used in field
trials, its operational procedures still need simplifying.
The specimen type for all of the tests evaluated here was serum,
which means the whole blood collected from donors should be
centrifuged or kept at a low temperature for a long time to
promote clot formation. The use of whole blood or dried whole
blood could negate the difficulties of processing and transporting
blood samples for serologic surveys in rural areas of P.R. China.
In conclusion, most immunodiagnostic tests evaluated had an
acceptable level of performance relative to the ‘gold’ standard
Kato-Katz technique. After considering all the requirements of
field diagnostics, i.e., sensitivity, specificity, validity, and ease of
use, the IHA_JX, DIGFA_SH, and ELISA_SZ were selected
for further field trials. With the caveat that the diagnostic approa-
ches may need to be adjusted to the stage of control and
the objective of the control activity [43], we expect to prioritize
those tools depending on the specific need [47,48], such as
screening chemotherapy targets, assessing the efficacy of schisto-
somiasis control programs or monitoring the endemic status of
schistosomiasis.
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Table 5. Operational characteristics of the evaluated tests.
Assay
code
Clarity of
instructions
Technical
complexity
Ease of interpretation
of results
Equipment required
but not supplied
Total
score
Technical
problem
IHA_AJ 3 2 2 0 7 No
IHA_HB 3 2 2 0 7 No
IHA_XY 3 2 2 0 7 No
IHA_JX 3 2 2 0 7 No
DIGFA_SH 3 3 3 1 10 Yes
DIGFA_XC 3 3 3 1 10 Yes
DIGFA_ZJ 3 3 3 1 10 Yes
MELISA_BE 3 1 1 0 5 No
ELISA_SZ 3 2 1 0 6 No
EITB 3 1 2 0 6 No
For each test, a score of 3 for the first three characteristics was given with 3 being the best, and then a score of 1 was given if the test does not require any additional
equipment.
doi:10.1371/journal.pntd.0000949.t005
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